0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Acute Lymphoblastic Leukemia FREE

Janet M. Torpy, MD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2009;301(4):452. doi:10.1001/jama.301.4.452.
Text Size: A A A
Published online

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and represents about one-quarter of all cancers among persons younger than 15 years. Acute lymphoblastic leukemia is a cancer of the blood and bone marrow (spongy tissue in the center of bone). In ALL, too many bone marrow stem cells develop into a type of white blood cell called lymphocytes. These abnormal lymphocytes are not able to fight infection very well. Also, as the number of these lymphocytes increases, there is less room for healthy white blood cells, red blood cells, and platelets. This may lead to infection, fatigue, and easy bleeding. The January 28, 2009, issue of JAMA includes an article about genetic variations associated with treatment response in childhood ALL. This Patient Page is based on one previously published in the March 21, 2007, issue of JAMA.

LEUKEMIA SYMPTOMS

  • Fatigue

  • Fever

  • Easy bruising

  • Bone pain

DIAGNOSTIC TESTS

  • Complete blood count (CBC)—a blood test that checks the number of red blood cells, white blood cells, and platelets.

  • Bone marrow aspiration—a needle is placed into the hip bone or breastbone and a sample of bone marrow is taken and examined for signs of cancer.

  • Cytogenetic analysis—lymphocytic cells taken from blood or bone marrow are examined to see if there are any changes in their chromosomes (genetic material).

  • Immunophenotyping—a test to see if cancer lymphocytes originated from B lymphocytes or T lymphocytes. This information is helpful in treating ALL.

PROGNOSIS AND TREATMENT

Prognosis (chance of recovery) from childhood ALL is usually very good; however, both prognosis and treatment depend on

  • Age and white blood cell count at diagnosis

  • Response to initial treatment

  • Origin of leukemia cells (from B or T lymphocytes)

  • Certain changes in the chromosomes of the lymphocytes

  • Involvement of the brain and spinal cord

Different types of treatment programs are available. Some programs are standard (currently used) and some are being tested in clinical trials (experimental). Most use chemotherapy (drug therapy). In addition, some patients may also need radiation therapy (use of high-energy x-rays) or bone marrow transplantation.

FOR MORE INFORMATION

INFORM YOURSELF

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A previous Patient Page on childhood leukemia was published in the January 28, 2004, issue.

Sources: American Cancer Society, American Academy of Pediatrics
Photo credit: Mihaela Onciu, MD/St Jude Children's Research Hospital

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

TOPIC: CHILDHOOD ILLNESSES

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Spanish Patient Pages
Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles